Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2020 Oct 1;18(10):1312-1320.
doi: 10.6004/jnccn.2020.0048.

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020

Dawn Provenzale  1 , Reid M Ness  2 , Xavier Llor  3 , Jennifer M Weiss  4 , Benjamin Abbadessa  5 , Gregory Cooper  6 , Dayna S Early  7 , Mark Friedman  8 , Francis M Giardiello  9 , Kathryn Glaser  10 , Suryakanth Gurudu  11 , Amy L Halverson  12 , Rachel Issaka  13 , Rishi Jain  14 , Priyanka Kanth  15 , Trilokesh Kidambi  16 , Audrey J Lazenby  17 , Lillias Maguire  18 , Arnold J Markowitz  19 , Folasade P May  20 , Robert J Mayer  21 , Shivan Mehta  22 , Swati Patel  23 , Shajan Peter  24 , Peter P Stanich  25 , Jonathan Terdiman  26 , Jennifer Keller  27 , Mary A Dwyer  27 , Ndiya Ogba  27
Affiliations
Practice Guideline

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020

Dawn Provenzale et al. J Natl Compr Canc Netw. .

Abstract

The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel's recommendations regarding the age to initiate screening in average risk individuals and follow-up for low-risk adenomas.

PubMed Disclaimer

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7–30. - PubMed
    1. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 2018;68:31–54. - PubMed
    1. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70:145–164. - PubMed
    1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130–160. - PubMed
    1. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739–750. - PubMed

Publication types